Wang H-F HF - OmicsDI

Show results for

Unknown (356)
Proteomics (60)
Metabolomics (18)
Transcriptomics (6)
Genomics (3)
Multiomics (1)

Organisms

Homo sapiens (50)
Mus musculus (10)
Arabidopsis thaliana (1)
Danio rerio (1)
Drosophila melanogaster (1)
Haemaphysalis longicornis (1)
Nitrosopumilus maritimus SCM1 (1)
Ricinus communis (1)
Solanum peruvianum (1)
Zea mays (1)

Repository

pride (53)
MetaboLights (17)
biostudies-arrayexpress (8)
MassIVE (5)
iProX (2)
EGA (1)
GNPS (1)

Tissue

Cell culture (14)
Cell line cell (7)
Epithelial cell (6)
HeLa cell (5)
T-47D cell (3)
UWB1.289 cell (3)
Blood plasma (2)
Endothelial cell (2)
HEK-293 cell (2)
HepG2 cell (2)
K-562 cell (2)
MDA-MB-231 cell (2)
Macrophage (2)
Placenta (2)
Skin (2)
Stem cell (2)
T cell (2)
Testis (2)
Adipocyte (1)
B cell (1)
Blood cell (1)
Blood serum (1)
Burkitt lymphoma cell line (1)
Cell suspension culture (1)
Colon (1)
Diploid cell (1)
Epididymal white adipose tissue (1)
HCC-70 cell (1)
Heart (1)
UWB1.289+BRCA1 cell (1)

Disease

Cervix carcinoma (3)
Breast cancer (2)
Malignant neoplasm of ovary (2)
Prostate adenocarcinoma (2)
Brain glioblastoma multiforme (1)
Burkitt lymphoma (1)
Cardiovascular system disease (1)
Colon cancer (1)
Colorectal cancer (1)
Disease free (1)
Kidney cancer (1)
Liver cancer (1)
Long COVID (1)
Lung cancer (1)
Melanoma (1)
Severe acute respiratory syndrome (1)

Technology Type

Mass Spectrometry (53)
Shotgun proteomics (31)
Mass spectrometry (14)
Gel-based experiment (7)
Data-dependent acquisition (5)
Bottom-up proteomics (4)
Mass spectrometry assay (3)
SWATH MS (3)
Affinity purification coupled with mass spectrometry proteomics (2)
All-ion fragmentation (2)
Top-down proteomics (2)
Data-independent acquisition (1)
MSE (1)
Proteogenomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (7)
Q Exactive HF (4)
Liquid Chromatography MS - negative - reverse phase (3)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (2)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (2)
Liquid Chromatography MS - alternating - hilic (2)
Liquid Chromatography MS - alternating - reverse phase (2)
Illumina HiSeq 2000 platform (1)
Illumina NovaSeq 6000 (1)
Illumina HiSeq 2000 (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion Lumos (1)
Q Exactive HF-X (1)
Q Exactive Plus (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - negative - HILIC (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive (1)
Liquid Chromatography MS - positive - HILIC (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2025 (15)
2023 (15)
2021 (11)
2024 (10)
2020 (8)
2026 (7)
2022 (6)
2019 (3)
2017 (3)
2014 (2)
2012 (2)
2010 (2)
2018 (2)

CHEBI ID

CHEBI:15741 (5)
CHEBI:16027 (5)
CHEBI:16235 (4)
CHEBI:16264 (4)
CHEBI:16359 (4)
CHEBI:16811 (4)
CHEBI:17596 (4)
CHEBI:18211 (4)
CHEBI:18257 (4)
CHEBI:25017 (4)
CHEBI:30915 (4)
CHEBI:32816 (4)
CHEBI:15354 (3)
CHEBI:15428 (3)
CHEBI:15756 (3)
CHEBI:15891 (3)
CHEBI:15971 (3)
CHEBI:16015 (3)
CHEBI:16040 (3)
CHEBI:16335 (3)
CHEBI:16349 (3)
CHEBI:16449 (3)
CHEBI:16551 (3)
CHEBI:16610 (3)
CHEBI:16680 (3)
CHEBI:16704 (3)
CHEBI:16708 (3)
CHEBI:16737 (3)
CHEBI:16750 (3)
CHEBI:16828 (3)

Metabolite Name

Cholic acid (4)
Guanine (3)
Guanosine (3)
Hypoxanthine (3)
Indolelactic acid (3)
Inosine (3)
L-asparagine (3)
L-aspartic acid (3)
L-glutamic acid (3)
L-glutamine (3)
L-histidine (3)
L-lysine (3)
L-proline (3)
Spermidine (3)
Tris(2-butoxyethyl) phosphate (3)
Uracil (3)
Uridine (3)
(2S,3S,4S,5R,6R)-6-[[(3S,4S,6aR,6bS,8aR,9R,12aS,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid (2)
1,11-Undecanedicarboxylic acid (2)
1-({[2-(2-furylmethyl)-5-methylpyrrolidinyl]amino}methylene)-7-[8-({[2-(2-fury lmethyl)pyrrolidinyl]amino}methylene)-1,6-dihydroxy-3-methyl-5-(methylethyl)-7 -oxo(2-naphthyl)]-3,8-dihydroxy-6-methyl-4-(methylethyl)naphthalen-2-one (2)
1-Stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (2)
2,6-Di-tert-butyl-4-hydroxymethylphenol (2)
9(10)-EpOME (2)
ADP (2)
AMP (2)
ATP (2)
Adenine (2)
Adenosine (2)
Capric acid (2)
Chenodeoxycholic acid (2)

Study type

Transcription profiling by array (2)
RNA-seq of non coding RNA (2)
Hi-C (1)
ChIP-seq (1)
Methylation profiling by high throughput sequencing (1)
RNA-seq of coding RNA (1)

Release Date

2022 (48)
2024 (46)
2021 (46)
2025 (37)
2023 (34)
2020 (31)
2019 (17)
2015 (16)
2017 (15)
2018 (14)
2016 (13)
2014 (11)
2012 (10)
2013 (8)
2011 (7)
2026 (5)
2010 (4)
2009 (2)

Lab affiliation

Cellzome (7)
Department of Pathology and Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA (2)
State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan, Hubei,China (2)
Universitätsmedizin Greifswald Interfakultäres Institut für Genetik und Funktionelle Genomforschung Abteilung für Funktionelle Genomforschung Felix-Hausdorff-Straße 8 17487 Greifswald (2)
Zhejiang University (2)
1.Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. 2.Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. (1)
1Department of Pathology, Dana-Farber/Harvard Cancer Center, PhD Program in Immunology, Harvard Medical School; Department of Laboratory Medicine, Boston Children's Hospital, Enders Research Building, Room 811, Boston, MA, 02115, USA (1)
Beijing Institute of Genomics, Chinese Academy of Sciences, China National Center for Bioinformation (1)
Children's Hospital of Fudan University (1)
Department of Biochemistry and Biophysics University of North Carolina Chapel Hill, NC USA (1)
Department of Biological Sciences College of Arts and Sciences University of South Carolina (1)
Department of Gastrointestinal Surgery, Shandong Provincial Hospital, jingwuweiqi street, 324, Jinan, Shandong 250021, China (1)
Department of Medicine II Haematology/Oncology Goethe University Theodor-Stern-Kai 7 60590 Frankfurt Germany (1)
Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu, China (1)
Division of Cell Biology, Histology and Embryology (1)
Division of Clinical Protein Science & Imaging, Department of Clinical Sciences (Lund), Department of Biomedical Engineering, Lund University, Lund, Sweden (1)
Doctor at Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China (1)
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA (1)
HeBeiMedical Unviersity (1)
Hebei normal university,China (1)
Institute of High Energy Physics, CAS (1)
Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, (1)
Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven 3000, Belgium (1)
Laboratory of Angiogenesis and Vascular Metabolism, VIB Center for Cancer Biology (CCB), VIB, Leuven, Belgium. Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven, Leuven, Belgium. (1)
Life Sciences Institute, Zhejiang University, Hangzhou, China. (1)
Nanjing Medical University (1)
Ping Xu, Ph.D. Secretary General of CNHUPO Professor, Director Department of Genomics and Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing) Beijing Institute of Lifeomics， 38 Life Science Park Road, Beijing 102206, P.R. China. Tel: 0086-10-61777113, Fax: 0086-10-61777060 (1)
School of Life Sciences, Westlake University, Hangzhou 310024, China (1)
Senior Postdoctoral Fellow Lew Laboratory Immunology Division The Walter and Eliza Hall Institute, Australia (1)
Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China. (1)

Previous page
1 / 45
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 45
Next page

Sort by:

Relevance

Page size

Landscape of gut microbiota and metabolites and their interaction in comorbid heart failure and depressive symptoms: a random forest analysis study

Depression is an individual risk factor for poor prognosis in patients with heart failure (HF). Recent studies show that gut microbiota and metabolites have critical role in comorbid HF and depressive symptoms. We recruited 95 subjects including 35 HF patients with depressive symptoms (HF-DS), 36...

2023-10-23 | MTBLS8183 | MetaboLights

The H/F substitution strategy can achieve large spontaneous polarization in 1D hybrid perovskite ferroelectrics.

Not available

S-EPMC11414823 | biostudies-literature

Haemaphysalis longicornis salivary gland LC-MSMS

Ticks are notorious carriers of pathogens; these blood-sucking arthropods can spread a variety of deadly diseases. The salivary gland is the main organ in ticks, and this organ begins to develop rapidly when Ixodidae ticks suck blood. When these ticks reach a critical weight, the salivary glands sto...

ORGANISM(S): Haemaphysalis longicornis

2020-05-26 | PXD013678 | Pride

Comprehensive Introduction to ASIAN-HF Registry.

Not available

S-EPMC12426648 | biostudies-literature

Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial.

Not available

S-EPMC11593999 | biostudies-literature

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy.

Not available

S-EPMC7809714 | biostudies-literature

Regulatory T cells promote endurance exercise adaptation by shielding muscle mitochondria from damage

Exercise enhances physical performance and reduces the risk of many disorders such as cardiovascular disease, type 2 diabetes, dementia and cancer. Exercise characteristically incites an inflammatory response, notably in skeletal muscles. While some effector mechanisms have been identified, regul...

2023-10-10 | MTBLS8391 | MetaboLights

SHengXIaN-QuYu DEcoction in the Treatment of Heart Failure with Reduced and Mildly-Reduced Ejection Fraction (SHINE-HF): rationale and design for a multicenter randomized controlled trial.

Not available

S-EPMC12152867 | biostudies-literature

4,4'-Bipyridine-2,3,4,5,6-penta-fluoro-benzoic acid (1/2).

Not available

S-EPMC2970439 | biostudies-literature

Differential gene expression profile in skin of Hoxc13 gene-targeted mice

Hoxc13 has been shown to be essential for proper hair shaft differentiation as Hoxc13 gene-targeted (Hoxc13tm1Mrc) mice completely lack external hair. Because of the phenotypic parallels to the Foxn1nu (nude) mutant mice, we tested whether Hoxc13 and Foxn1 act in a common pathway of hair follicle (H...

ORGANISM(S): Mus musculus

2010-08-25 | E-GEOD-23759 | biostudies-arrayexpress

Previous page
1 / 45
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 45
Next page

Sort by:

Relevance

Page size

443 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets